Nearly 90,000 Children’s Ibuprofen Bottles Recalled Over Contamination Concerns

Children’s Ibuprofen Recalled Over Contamination Risk | Healthcare 360 Magazine

Children’s Ibuprofen Recalled nationwide after nearly 90,000 bottles were found to contain foreign material contamination, prompting federal health officials to warn of potential temporary health risks and urge consumers to stop use immediately.

U.S. health regulators say 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 milligrams per five milliliters, are affected. The medication is widely used to reduce fever and relieve pain in children.

The recall was initiated March 2 by Strides Pharma Inc. after the company received complaints about a “gel-like mass and black particles” found in the product. The bottles were manufactured by Taro Pharmaceuticals and distributed to retailers nationwide.

Company Initiates Recall After Reports of Foreign Particles

Children’s Ibuprofen Recalled following multiple consumer complaints, though the exact number remains unclear. Officials confirm that no injuries or illnesses have been reported as of Thursday.

In a report, the U.S. Food and Drug Administration said the presence of foreign material could compromise product safety and quality. The agency defines recalls as actions taken when products present a risk of injury or are otherwise defective.

The affected products come in four-fluid-ounce bottles with an expiration date of Jan. 31, 2027. The recalled lot numbers are 7261973A and 7261974A.

FDA Classifies Recall as Moderate Health Risk

Children’s Ibuprofen Recalled after the FDA classified the event as Class II on March 16. This designation indicates that use of the product may cause temporary or medically reversible adverse health effects but is unlikely to result in serious harm.

Health experts say contaminants in liquid medication can pose risks, particularly for children, who are more vulnerable to impurities. The FDA advises consumers to discontinue use of the affected product immediately.

“The classification reflects a situation where the probability of serious health consequences is low, but caution is still warranted,” the agency said in its notice.

Consumers Urged to Check Lot Numbers and Stop Use

Consumers are advised to check lot numbers on packaging after Children’s Ibuprofen Recalled batches were identified. If the product matches the recalled lots, they should stop using it immediately and contact the retailer or manufacturer for return or refund instructions.

Pharmacies and retailers have been directed to remove the affected products from shelves. The recall applies nationwide, though it is not yet clear how widely the product was sold.

Children’s Ibuprofen Recalled after Strides Pharma did not immediately respond to requests for comment. Health officials continue to monitor the situation and advise caregivers to consult a health professional if a child experiences unusual symptoms after taking the medication.

The FDA says it will provide updates if additional information becomes available.

Visit Healthcare 360 Magazine For The Most Recent Information.

Most Popular Stories